Skip to Main Content

Paper Details

Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin.
Intern Emerg Med
12
2017
Author NameAffiliation
William F PeacockBaylor College of Medicine
Gregory J FermannUniversity of Cincinnati
  • 1 - 2

Datasets

Release 1.2